Login / Signup

Narrative review of current status and recommendations in treatment for advanced triple-negative breast cancer.

Yan ZhouJin Yang
Published in: Translational breast cancer research : a journal focusing on translational research in breast cancer (2022)
It was emphasized that the detection and evaluation of biomarkers or targeting molecules should be the basis for choosing therapeutic regimens in this review and clinicians are supposed to accurately screen the population to achieve better treatment outcomes and prognosis for patients with advanced TNBC.
Keyphrases
  • current status
  • palliative care
  • high throughput
  • label free
  • replacement therapy
  • single cell